![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/biotech/codiak-biosciences-files-bankruptcy-after-unable-satisfy-financial-needs
https://www.globenewswire.com/news-release/2023/03/27/2634618/0/en/Codiak-BioSciences-to-Pursue-Asset-Sale-through-Voluntary-Chapter-11-Process.html
https://www.globenewswire.com//news-release/2022/11/28/2563447/0/en/Codiak-BioSciences-to-Participate-5th-Annual-Evercore-ISI-HealthCONx-Conference.html
https://www.globenewswire.com/news-release/2022/11/03/2548229/0/en/Codiak-BioSciences-Reports-Third-Quarter-2022-Financial-Results-and-Operational-Progress.html
https://www.globenewswire.com/news-release/2022/10/12/2532827/0/en/Codiak-Presents-Preclinical-Data-Demonstrating-its-Pan-Beta-Coronavirus-Vaccine-Elicits-Broad-Protective-Immunity-Against-Known-Variants-of-SARS-CoV-2-and-Related-Sarbecoviruses.html
https://www.globenewswire.com/news-release/2022/10/05/2528627/0/en/Codiak-to-Present-New-Preclinical-Data-Demonstrating-Potent-Monotherapy-Activity-of-Two-Engineered-Exosome-Intravenous-Candidates-Targeting-Macrophages.html
https://www.globenewswire.com/news-release/2022/09/13/2514560/0/en/Codiak-Announces-Pricing-of-20-Million-Public-Offering-of-Common-Stock-and-Warrants.html
https://www.globenewswire.com/news-release/2022/09/12/2514465/0/en/Codiak-Announces-Proposed-Public-Offering-of-Common-Stock-and-Warrants.html
https://www.globenewswire.com/news-release/2022/08/30/2506865/0/en/Codiak-BioSciences-Announces-Program-Reprioritization-and-Corporate-Restructuring.html